Company news
Ondine Biomedical, Inc. news in 2023
Ondine Biomedical, Inc.'s news releases, calls and decks from 2023, newest first.
C$4.91 raise supports ongoing commercialisation
December 13, 2023
TR-1: notification of major holdings
December 12, 2023
Result of Placing & Broker Option Update
December 5, 2023
Close of Bookbuild
December 4, 2023
Update. Re investor-led financing
December 1, 2023
Ondine announces investor-led financing
November 30, 2023
Photodisinfection recommended as Standard of Care
November 16, 2023
Ondine Biomedical’s nasal photodisinfection named as leading photonics biomedical technology for its potential to safely combat AMR
November 13, 2023
Steriwave use expanded following successful pilot
October 31, 2023
66.5% reduction in spine surgery infection rate
October 23, 2023
Steriwave shown to reduce resistant bacteria
October 18, 2023
Steriwave now in Canada's East Coast
October 13, 2023
Ondine to present poster at IP2023, Liverpool
October 10, 2023
Hospital to adopt Steriwave as standard-of-care
October 9, 2023
Burnaby Hospital deploys Steriwave
September 29, 2023
Half-year Report
September 25, 2023
Montreal Heart Institute pilots Steriwave
September 21, 2023
Steriwave proven effective against XDR bacteria
September 14, 2023
Steriwave evaluation at major heart institute
September 12, 2023
Ondine to present new AMR research at ICPIC Geneva
August 29, 2023
Issue of Equity and TVR
August 21, 2023
Ondine technology used in major Canadian hospital
August 7, 2023
Ondine commences first NHS Steriwave® pilot
August 1, 2023
Ondine receives impact award at IPA World Congress
July 17, 2023
Corporate Update
July 7, 2023
Photodisinfection cuts COVID in meat processing
June 22, 2023
Result of AGM
May 25, 2023
Annual Report for the Year Ended 31 December 2022
May 23, 2023
Full Year Results
May 10, 2023
Issue of Equity
May 3, 2023
Ondine reports successful food pathogen study
April 20, 2023
Ondine Phase 2 results presented at ECCMID 2023
April 18, 2023
Progress Update
April 17, 2023
Ondine food-safe photodisinfection update
April 5, 2023
Lux Vitae advocates Steriwave for COVID prevention
March 7, 2023
Ottawa hospital presents Steriwave study results
March 3, 2023
Grant of Share Options
February 22, 2023
Ondine's APDT reduces SARS-CoV-2 infectivity
January 31, 2023
TR-1: Notification of major holdings
January 17, 2023
Second Price Monitoring Extn
January 13, 2023